XML 46 R19.htm IDEA: XBRL DOCUMENT v2.4.0.6
Acquisitions (Tables) (Phygen, LLC [Member])
3 Months Ended
Mar. 31, 2013
Phygen, LLC [Member]
 
Purchase Price Consideration Based on Common Stock and Cash Consideration

Based on the closing price of Alphatec’s common stock of $1.69 on November 6, 2012, cash consideration and contingent liabilities, the total purchase price for Phygen was as follows (in thousands):

 

Fair value of Alphatec common stock issued upon closing

   $ 8,856   

Cash consideration paid and payable

     5,900   

Contingent consideration

     3,654   
  

 

 

 

Total purchase price

   $ 18,410   
  

 

 

 
Allocation of Purchase Price and Estimated Useful Life of Assets Acquired

The following table summarizes the allocation of the preliminary purchase price (pending final valuation of intangible assets, deferred income taxes and inventory valuation) for Phygen and the estimated useful lives for the acquired intangible assets (in thousands):

 

     Useful lives
(in years)
     Estimated
Fair Value
 

Net tangible assets assumed

      $ 1,204   

Acquired intangibles:

     

Developed technology

     3         176   

Trademarks

     3         59   

Covenant not-to-compete

     3         384   

Customer-related intangibles

     12         6,239   

Distribution network

     12         2,366   

Goodwill

        7,982   
     

 

 

 

Total purchase price allocation

      $ 18,410